SCHEMBL2652048

SCHEMBL2652048

Cc1cc(-c2ccc(C(F)(F)F)cc2)ccc1CC(C)COc1ccc(C(=O)NCCC(=O)O)cc1

nearest known ligand 0.48

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GCGR P47871 18/20 0.48
GIPR P48546 3/20 0.47
GCG P01275 2/20 0.45
PPARD Q03181 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2653550 0.87 GCGR (0.49) GCGRGIPRGCGPPARD
SCHEMBL2276868 0.87 SPHK2 (0.49) GCGRGIPRPPARD
SCHEMBL2652237 0.85 MEN1 (0.49) GCGRGIPRGCGPPARD
SCHEMBL2654059 0.82 GCGR (0.50) GCGRGIPRGCGPPARD
SCHEMBL2653527 0.82 GCGR (0.55) GCGRGIPRGCGPPARD
SCHEMBL2269506 0.81 RXRA (0.54) GCGRGIPRGCGPPARD
SCHEMBL2654147 0.81 FFAR1 (0.48) GCGRGIPRGCGPPARD
SCHEMBL2655260 0.80 GCGR (0.45) GCGRGIPRPPARD
SCHEMBL2270504 0.80 GCGR (0.52) GCGRGIPRGCG
SCHEMBL2270499 0.80 GCGR (0.52) GCGRGIPRGCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758859-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP claimed
WO-2005118542-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-15 WO claimed
EP-1758859-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP disclosed
WO-2005118542-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-15 WO disclosed